Solid Update , I'm satisfied
For those on the forum that confuse Spruiking and Company Marketing to Create Market Awareness.
As Biotechs progress and over come significant Milestones it's Managements Job to Ensure Share Holder Value,,, simply put when a Biotech or Baby Pharma Carry out Trials Phase I and II (Value Circa $1.5m to $5m) then upon data (positive) the company needs to INFORM the wider investment community of the companys success's.. This is how a non revenuing Biotech or Baby Pharma demonstrates Progress moving toward the final results -reducing investment risk and promoting a positive commercial outcome for Shareholders .
When I speak of increase Marketing , That is to make the Investment Community Aware of Progress,, Greater Awareness of a commercial opportunity means Higher Participation which translates into higher demand.
Why is this important , firstly we know that incremental increases as we progress demonstrate the market understand what the company are out to achieve and over coming those monumental Milestones are the Value Triggers,,, Incremental Increases also dont attract a speeding ticket from the ASX,,, so when PAA make a 3 line statement in the Q that Dogs have been enrolled and dosed only those that read the PAA Q are immediately aware.. I know of at least 6 SH that have emailed surrounding "Recruitment and Dosing" so the company would be Fully aware how important those announcements are in the Creation of a Valuable Biotech. Not Announcing to Market that K9's had been Recruited and Dosed is an Opportunity Lost to gain greater Market exposure to potential Shareholders and K9 dog owners for recruiting.
Human Nature is not to be first in line,,,,so a Headline that Trials were underway and dogs recruited would have been a significant shot in the arm for PAA awareness.
As for the new pills ,, Efficacy is a major factor in Optimum Drug/Dose Delivery ,,, PAA can test the Older pills for Efficacy against the new batch,,, some meds deteriorate very quickly and lose significant efficacy ,, My Understanding is Pharmapantal will be Sold in 1 month units, With the high number of potential customers ,,Millions ,, the batches will always be fresh ... so thats what will be the closest to our Retail Product.
You would have to go a way back but the MPL Tablets that have been produced are our retail Product , so there is a significant time-saving should the Phase II be successful plus the Pills are manufactured to fit a specific Price Point.
Do I wish for greater Transparency "Yes" and for the company to take advantage of every single opportunity to gain Editorial Content surrounding their Progress and Success to date.... otherwise if there is no information flow from the company then PAA are invisible to the wider Investment Community..
You only have to look at the PAA Graph for 6 months,,,,thats what the Market response to Company Silence ,, Value erosion since starting Phase II $24m AUD
So "NO" i dont want spruiking just an informed update of progress so that progress can be attributed to our MC the Market Value of PAA....
Expand
(20min delay)
